Metastatic cancer treatment market to reach $111.16b by 2027

Thanks to therapy advancements and a rise in R&D investments.

The global metastatic cancer treatment market is projected to grow at a compound annual growth rate of 7.3%, increasing from $63.03b in 2019 to $111.16b by 2027, said GlobalData.

The sector’s expansion is attributed to advancements such as molecular targeted therapy and immunotherapy, along with a rise in research and development investment.

Moreover, initiatives promoting minimally invasive treatments and medical tourism in India and Japan are driving the market.